Respiratory failure & ventilation

Lower or higher oxygenation targets in the intensive care unit: an individual patient data meta-analysis

Intensive Care MedPublished Individual patient data meta-analysis of the Handling Oxygenation Targets in the ICU (HOT-ICU) and HOT-COVID randomised trials

Pooled result · All-cause mortalityResult — go to the resultRelative risk 0.99 95% CI 0.92–1.07

Authors' conclusion

This study reported no overall differences comparing a PaO2 target of 8-12 kPa on mortality or days alive without life support in 90 days.

Study context

Population
Adult intensive care unit (ICU) patients with acute hypoxemic respiratory failure2 RCTs
Participants
1,792 vs 1,793
Comparison
Pressure of arterial oxygen (PaO2) target 8 kPa vs 12 kPa
  • 8 kPan = 1,792
  • 12 kPan = 1,793reference
Outcome
All-cause mortality
Follow-up
90 days
Methodological detailspre-specified, heterogeneity of treatment effects (HTE) evaluated in 14 subgroups, graded with ICEMAN
  • Pre-specified
  • HTE evaluated in 14 subgroups, graded with ICEMAN

Pooled result

As reported in the abstract

Relative risk

0.99

95% CI 0.92–1.07

P = 0.80

Events by group

8 kPa vs 12 kPa
RR 0.99 (95% CI 0.92–1.07); P = 0.80

Further pooled results

Days alive without life support · 90 days

No difference observed

Days alive without life support (COVID-19 subgroup)

More days alive without life support targeting 8 kPa
P = 0.04
  • Moderate credibility

Mortality (cancer subgroup)

Lower mortality targeting 12 kPa
P = 0.03
  • Low credibility

Days alive without life support (cancer subgroup)

More days alive without life support targeting 12 kPa
P = 0.02
  • Low credibility

Original publication

Lower or higher oxygenation targets in the intensive care unit: an individual patient data meta-analysis. Intensive Care Med. Published 11 July 2024. doi:10.1007/s00134-024-07523-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.